Wells Fargo & Company TONIX PHARMACEUTICALS HLDG C Transaction History

Wells Fargo & Company

  • $429 Billion
  • Q1 2025

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
SELL
N/A
-57,257 Closed
0 $0
Q1 2022

May 16, 2022
SELL
N/A
-163,448 Reduced 74.06%
57,257 $13,000
Q4 2021

Feb 14, 2022
BUY
N/A
206,418 Added 1444.8%
220,705 $79,000
Q3 2021

Nov 15, 2021
SELL
N/A
-4,342 Reduced 23.31%
14,287 $9,000
Q2 2021

Aug 16, 2021
BUY
N/A
2,242 Added 13.68%
18,629 $21,000
Q1 2021

May 13, 2021
SELL
N/A
-170,613 Reduced 91.24%
16,387 $21,000
Q4 2020

Feb 09, 2021
BUY
N/A
186,200 Added 23275.0%
187,000 $126,000
Q3 2020

Nov 05, 2020
BUY
N/A
619 Added 341.99%
800 $1,000
Q2 2020

Aug 13, 2020
BUY
N/A
98 Added 118.07%
181 $0
Q1 2020

May 14, 2020
BUY
N/A
83 New
83 $0
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email